53 search results for: symptoms

The Pathophysiology of Prurigo Nodularis
Dermatology
The Pathophysiology of Prurigo Nodularis
videoanimation

An infographic exploring the pathophysiology of prurigo nodularis and the role of type 2 inflammation.

View more
Impact of Exacerbations in COPD
Type 2 Inflammation
Impact of Exacerbations in COPD
expert video

Dr. Stephanie Christenson discusses the association between COPD exacerbations and the increased risks of morbidity and mortality

View more
The PEDISTAD Survey: Assessing the Burden of Atopic Dermatitis in the Global Pediatric Population
Dermatology
The PEDISTAD Survey: Assessing the Burden of Atopic Dermatitis in the Global Pediatric Population
Infographic

An interactive tool used to explore the global burden of atopic dermatitis in children and adolescents.

View more
Type 2 Inflammation: Links With Severe Uncontrolled CRSwNP
Rhinology
Type 2 Inflammation: Links With Severe Uncontrolled CRSwNP
expert video

In this video soundbite from the ERS-ISIAN 2025 symposium, Dr. Vibeke Backer discusses how Type 2 inflammation drives severe, uncontrolled CRSwNP. It covers key immune cells and biomarkers (e.g., IL-4, IL-5, IL-13, TSLP), global prevalence differences, and the importance of symptom tracking and targeted therapies.

View more
Bullous Pemphigoid (BP): Exploring New Frontiers
Dermatology
Bullous Pemphigoid (BP): Exploring New Frontiers
expert video

Join experts Dédée Murrell, Donna Aline Culton, Joost Meijer and Enno Schmidt for an educational presentation on the clinical presentation, disease burden, diagnosis, and underlying pathophysiology of bullous pemphigoid (BP). Dive deeper into unmet needs and treatment challenges faced by these patients and how targeted therapies may address them.

View more
Explore the clinical presentations of bullous pemphigoid (BP), the steps for diagnosis, and the burden of disease.
Dermatology
Bullous Pemphigoid (BP): Don't Miss the Diagnosis
Infographic

This static infographic covers the clinical presentations, diagnostic challenges, and disease burden of bullous pemphigoid (BP), a chronic relapsing autoimmune skin disease. Review the steps of diagnosis, which include clinical assessment and laboratory work. Explore comorbidities associated with BP and how they impact patient quality of life.

View more
Chronic Obstructive Pulmonary Disease: Disease Burden & Heterogeneity
Pulmonology
Chronic Obstructive Pulmonary Disease: Disease Burden & Heterogeneity
interactivity

Learn about the disease burden and heterogeneity of chronic obstructive pulmonary disease (COPD).

View more
What Could Remission Mean in AD?
Dermatology
What Could Remission Mean in AD?
expert video

Dr. Simpson explores the concept of remission in AD, focusing on minimal disease activity and long-term remission, discussing how disease modification in AD can impact the course of the disease and its associated comorbidities.

View more
The Shared Path: Type 2 Inflammation As a Driver of Chronic Itch
Dermatology
The Shared Path: Type 2 Inflammation As a Driver of Chronic Itch
expert video

Professor Matthias Augustin highlights the role of type 2 inflammation in chronic itch across distinct pruritic skin diseases and the cumulative burden of chronic itch and skin lesions in PN.

View more
Understanding the Full Scope of PN: Lesions, Dyspigmentation, and Patient Burden
Dermatology
Understanding the Full Scope of PN: Lesions, Dyspigmentation, and Patient Burden
expert video

Professor Matthias Augustin details the various clinical manifestations of prurigo nodularis, illustrating how different lesion types can present concurrently in patients.

View more
The Clinical Presentation of CSU is Heterogeneous
Dermatology
The Clinical Presentation of CSU is Heterogeneous
expert video

Dr Hawkes provides an overview of the distinctive characteristics of wheals and angioedema in clinical manifestation

View more
CSU is Unpredictable in its Course and Duration
Dermatology
CSU is Unpredictable in its Course and Duration
expert video

Dr. Hawkes highlights how Chronic Urticaria is a mast cell centric disease with moderate levels of spontaneous remission in patients.

View more